Press Archives
FOR IMMEDIATE RELEASE
November 29, 2007
Contact: Jewelle Yamada – (212) 207-0574
Sumitomo Corporation Appoints new Chairman to U.S. Animal Healthcare Company Summit VetPharm, LLC
Sumitomo Corporation of America (SCOA) announced the appointment of Mr. Koichi Isohata as Chairman of its newest subsidiary, animal healthcare company, Summit VetPharm, LLC. Mr. Isohata joins the Summit VetPharm management team after spending over 15 years as head of Sumitomo's Household Insecticides and Agrochemical business in Tokyo, and serving as general manager for the Petcare business in the Life Science Division, Chemical and Electronics Business Unit, in charge of the establishment of Summit VetPharm.
Summit VetPharm is headquartered in Fort Lee, New Jersey and was founded by veterinarians and experienced industry professionals who share a deep respect for companion animals and veterinarians. Julia Stephanus, President and CEO of Summit VetPharm, has more than 25 years experience in the pharmaceutical industry where she has been closely involved in the commercial development and launch of breakthrough animal health care drugs such as Rimadyl(R) and Revolution(R).
"Mr. Isohata's leadership and talents will complement Ms. Stephanus' experience and knowledge in the industry and will be invaluable to Summit VetPharm as they continue to grow as a company and expand their product line," said Mr. Tatsuya Suto, Senior Vice President and General Manager of the SCOA Chemical Group. "He brings both high-level operational experience and a good understanding of the animal healthcare market."
Members of the Summit VetPharm management team include, Monique Schwartz, Director of Marketing, with more than 27 years sales and marketing experience in animal health and parasiticides, having worked on the launch of Heartgard and Revolution; and Bruce Truman, Senior Director of Sales and Customer Service, with 15 years experience working with several major animal health care companies managing leading brands such as Frontline and Revolution.
With a deep understanding of veterinarians and their needs, Summit VetPharm is uniquely focused on servicing professional veterinarians and their staff by providing innovative new products exclusive to veterinarians; veterinarian-friendly policies and procedures; high-performance, well-trained representatives; data and continuous education to support its products and in- depth knowledge of pet owners and their decision-making process. Summit VetPharm also provides education for the veterinary healthcare team, including continuing education, clinical research articles, and veterinary school programs. Summit VetPharm's commitment to the veterinary-client-patient relationship is further reinforced by their Bloodhound(TM) tracking technology - an innovative, proprietary track and trace system which prohibits diversion of products into sales channels outside of the veterinarian clinic.
With a focus on serving the veterinary community, Summit VetPharm plans to offer a range of unique and valued products and services that will help veterinary practices in the U.S.
For instance, seeing a need to address the issue of growing resistance among fleas and ectoparasites to current insecticide products on the market, Summit VetPharm's first product is an innovative new ectoparasiticide and includes Dinotefuran, a new third-generation neonicotinoid active that has remarkable "speed of kill" and will help combat resistance. In late September, Summit VetPharm introduced Vectra 3D(TM), a new broad-spectrum topical combining Dinotefuran with a pyrethroid and an insect growth regulator (IGR) in a formula that effectively protects dogs against three vectors - fleas, ticks, and mosquitoes. The company's studies show that Vectra 3D delivers efficacy of at least 30 days. Vectra 3D's new insecticide is colorless, odor free, non-greasy, quick-drying and water- resistant.
"Ectoparasites have never been exposed to this new molecule," according to Dr. Albert Ahn. The original research work on Vectra 3D was conducted by the founding employees of Summit VetPharm who are all veterinary professionals. The development work was funded by Sumitomo Corporation and all registrations and patents are now owned by Summit VetPharm. Vectra 3D, containing Dinotefuran was developed exclusively for the veterinary channel. With the exclusive rights to Vectra 3D and Dinotefuran in the companion animal market Summit VetPharm holds the EPA Registration No. 83399-6 for Vectra 3D, and is the sole owner of the federal and state registrations and all patents associated with the Vectra 3D product.
In studies conducted both in the laboratory and in the field, Vectra 3D has shown no clinically significant treatment-related adverse events, and exhibits a rapid knockdown effect.
"Vectra 3D has demonstrated remarkable speed of kill and reinfestation protection in all weight ranges of dogs," according to Dr. Ahn. Vectra 3D kills 96 percent of adult fleas within six hours, 100% within 12 hours, repels other fleas from attaching to the dog and prevents development of flea eggs, larvae and pupae. It also repels and kills four species of ticks (Black- legged Deer tick, Brown Dog tick, American Dog tick and Gulf Coast tick) and three species of mosquitoes (Culex spp., Ochlerotatus spp. and Aedes spp.)
"With the increased threat of vector borne diseases, the ability to
kill and repel these parasites is extremely important. Vectra 3D kills the vectors that can cause Lyme disease, Rocky Mountain Spotted fever, babesiosis, ehrlichiosis, bartonellosis, hepatozoonosis, tapeworm and heartworm disease," explains Dr. Ahn.
"The last decade has seen remarkable advancements in animal healthcare, and Summit VetPharm looks to further extend the range of beneficial veterinary pharmaceutical options for companion animals", said Stephanus. "Summit will provide novel products and services which will enhance the veterinarian- client-patient relationship and help companion animal veterinary professionals grow their practices."
"Companion animal healthcare is the driving force behind the research and development of new products at Summit VetPharm," says Stephanus.
Besides being the first topical product on the market that effectively eliminates three types of parasites with the total protection of a flea IGR for at least a month, Vectra 3D is gentle enough for puppies seven weeks of age.
Vectra 3D also features a first-of-its-kind patented applicator that
veterinarians and pet owners will appreciate. No other company offers the unique easy-to-open applicator that Vectra 3D has which features an elongated tip that makes it quick and easy to apply to a dog's skin through the hair coat. The one-piece applicator has no cap and requires no scissors to open, and eliminates splash back and spilling. The rounded tip also minimizes risk of skin abrasions.
Summit VetPharm is committed to ensuring that Vectra 3D is dispensed only through licensed veterinarians through its new Bloodhound(TM) Technology and any veterinarian interested in selling Vectra 3D is required to sign a written agreement that helps the company maintain the integrity of its products through a secure distribution channel, as well as, guarding against the growing problem of diversion and counterfeiting.
"By securing our supply chain, we are able to protect the veterinary professional, maintain authenticity of our products, and enhance the role of veterinarians in the lives of the animals they treat," states Stephanus.
In addition to its own national sales team, Summit VetPharm also
recently announced a co-promotion agreement with Abbott Animal Health for the sales of the Vectra line of products.
Additionally, the company has signed distribution agreements with the following wholesale veterinary distributors: Henry Schein/NLS Animal Health, Midwest Veterinary Supply, Inc., Merritt Veterinary Supplies, Inc., Victor Medical Company, Northeast Veterinary Supply Company (NEVSCO), Associated Medical Supply, Great Western Animal Health Supply, Inc., and Sanum Puerto Rico.
Summit VetPharm
Founded by veterinarians and experienced industry professionals, Summit VetPharm is committed to protecting the health and welfare of both companion animals and companion animal veterinary practices. As a wholly-owned subsidiary of the Sumitomo Corporation and part of the Sumitomo Corporation group of companies, Summit VetPharm is backed by a longstanding reputation for values and ethics in business and is dedicated to raising the standards in animal health. Summit VetPharm is headquartered in Fort Lee, New Jersey, USA. For more information, visit Summit VetPharm at www.summitvetpharm.com
FOR IMMEDIATE RELEASE
September 12, 2007
Contact: Jewelle Yamada – (212) 207-0574
New Topical Vectra 3DTM Provides Dogs Long-Lasting Protection from Fleas, Ticks and Mosquitoes
Dinotefuran, Pyriproxyfen, Permethrin Combination Delivers Faster, Effective and More Complete Relief for Dogs
The chronic nature of flea and tick control contributes to the potential for resistant fleas and ectoparasites. The introduction of Vectra 3D with Dinotefuran, a new third-generation neonicotinoid will help combat resistance. “Ectoparasites have never been exposed to this new molecule,” said Dr. Albert H. Ahn, DVM. “Our studies show that Vectra 3D is as effective on day 30 as it is on day one.”
Vectra 3D’s new insecticide is colorless, odor free, non-greasy, quick-drying and water- resistant. In studies conducted both in the laboratory and in the field, Vectra 3D has shown no clinically significant treatment-related adverse events, and has a rapid knockdown effect. “Vectra 3D has demonstrated remarkable speed of kill and reinfestation protection in all weight ranges of dogs,” according to Ahn.
Vectra 3D kills 96 percent of fleas within six hours, repels other fleas from attaching to the dog and prevents development of flea eggs, larvae and pupae. “Pet owners want fleas killed as quickly as possible to end their dogs’ suffering,” Ahn says. “Oftentimes, the successive feeding activity of fleas on dogs elicits a hypersensitivity skin disorder known as flea allergy dermatitis (FAD). Treatment of dogs with Vectra 3D rapidly kills fleas and may reduce further evidence of FAD.” Vectra 3D repels and kills four species of ticks (deer tick, brown dog tick, American dog tick and Gulf Coast tick) and three species of mosquitoes (Culex, Ochlerotatus and Aedes). “With the increased threat of vector borne diseases, the ability to kill and repel these parasites is extremely important. Vectra 3D kills the vectors that can cause Lyme disease, Rocky Mountain spotted fever, babesiosis, ehrlichiosis, bartonellosis, hepatozoonosis, tapeworm and heartworm disease,” explains Ahn.
Vectra 3D features a combination of new and proven ingredients that provide faster, longer and more complete relief for dogs. The triple-action formula includes:
- Dinotefuran – a new, fast-acting, third generation neonicotinoid with a novel mode of action.
- Permethrin – a proven, broad-spectrum molecule that works with dinotefuran to repel and kill fleas, ticks and mosquitoes.
- Pyriproxyfen – a superior growth regulator (IGR) that prevents development at all flea stages including eggs, pupae and larvae.
“As a veterinarian, I know that the current spot-on ectoparasiticidal products have set the standard for efficacy. Summit VetPharm is building and improving upon this achievement with the launch of the Vectra 3D product,” said Ahn. “Vectra 3D will be the first product on the market that effectively eliminates three types of parasites with the total protection of a flea IGR. The added bonus is that it works for at least a month and is gentle enough for puppies seven weeks of age.”
Vectra 3D also includes major improvements for dog owners. The unique, patented applicator features an elongated tip that makes it easy to apply to a dog’s skin through the haircoat. The rounded tip minimizes risk of skin abrasions. The easy-to-open applicator eliminates splash back and spilling, and the contoured shape makes it easier to handle. With the one-piece applicator, there is no need to use scissors to open or remove a cap, making application fast and efficient and at the same time, minimizing the potential of a choking hazard.
Vectra 3D is protected with Summit VetPharm’s new Bloodhound™ Technology - an innovative, proprietary track and trace system developed by Nutec Systems that ensures veterinary exclusivity of the product. Each package of Vectra 3D can be traced from the point of manufacture to veterinary purchase. Bloodhound Technology will allow Summit VetPharm to maintain the integrity of its products through a secure distribution channel, as well as, guarding against counterfeiting.
“By securing our supply chain, we are able to protect the veterinary professional, maintain authenticity of our products, and enhance the role of veterinarians in the lives of the animals they treat. Through our Bloodhound Technology, we can help keep companion animal health exactly where it belongs — in the hands of professionals,” states Julia Stephanus, president of Summit VetPharm. Vectra 3D’s new triple-action topical parasite formula is available to pet owners only through licensed veterinarians.
Vectra 3D is available in four different sizes: for dogs and puppies over 7 weeks of age weighing 2.5 to 20 pounds; 21 to 55 pounds; 56 to 95 pounds, and for dogs over 95 pounds. Summit VetPharm recently announced a co-promotion agreement with Abbott Animal Health. This new partnership will strengthen Summit VetPharm's contributions to veterinarian-client-patient care by combining the innovative products and commercial expertise of Summit with the sales capability and reach of Abbott Animal Health.
Vectra 3D is currently available to veterinarians from the following distributors: NLS Animal Health, a division of Henry Schein Inc, Midwest Veterinary Supply, Inc., Merritt Veterinary Supplies, Inc., and Victor Medical Company, Hawaii Mega-Cor and Sanum Puerto Rico, Inc.
Summit VetPharm
Founded by veterinarians and experienced industry professionals, Summit VetPharm is committed to protecting the health and welfare of both companion animals and companion animal veterinary practices. As a wholly-owned subsidiary of the Sumitomo Corporation and part of the Sumitomo Corporation group of companies, Summit VetPharm is backed by a longstanding reputation for values and ethics in business and is dedicated to raising the standards in animal health. Summit VetPharm is headquartered in Fort Lee, New Jersey, USA . For more information, visit Summit VetPharm at www.summitvetpharm.comFOR IMMEDIATE RELEASE
July 14, 2007
Contact: Jewelle Yamada – (212) 207-0574
New Animal Healthcare Company Summit VetPharm Focuses On Companion Animals and Veterinarians
Summit VetPharm, LLC, a newly formed animal healthcare company headquartered in Fort Lee, New Jersey, announced its entry into the field of companion animal healthcare products, during the 144th annual meeting of the American Veterinary Medical Association in Washington, D.C., July 14-18.
With a focus on serving the veterinary community, companion animals and their owners, Summit VetPharm is planning to offer a range of unique and valued products and services to veterinary practices in the U.S. Today, Summit VetPharm introduced its senior management and professional team to the veterinary community at a special reception held at the prestigious National Music Center and Museum Foundation at the Historic Carnegie Library in Washington, D.C.
“The last decade has seen remarkable advancements in animal healthcare, and Summit VetPharm looks to further extend the range of beneficial veterinary pharmaceutical options for companion animals”, said Summit VetPharm’s President Julia Stephanus. “Summit will provide novel products and services which will enhance the veterinarian-client-patient relationship and help companion animal veterinary professionals grow their practices.”
Companion animal health is the driving force behind the research and development of new products at Summit VetPharm. The company’s first discovery, Dinotefuran, is achieving exciting results in companion animal parasiticide control. Dinotefuran is a fast-acting, highly efficacious third-generation neonicotinoid. It has broad insecticidal activity for control of ectoparasites and superior long-term tolerability.
Summit VetPharm offers high-quality products and technologies that are distributed exclusively through veterinarians to guarantee safety and authenticity. Summit VetPharm will ensure the veterinary exclusivity of all its products with its innovative Bloodhound™ Technology, a track and trace system developed by Nutec Systems. This ground-breaking technology tracks all Summit VetPharm products from point of manufacture to veterinary purchase, assuring they are available to consumers only through licensed veterinarians.
Summit VetPharm also recently announced they have entered into a co-promotion agreement with Abbott Animal Health. Together, they will launch an exciting portfolio of companion animal products in the near future.
Additionally, the company has signed distribution agreements in the continental US with the following wholesale veterinary distributors:
NLS Animal Health/ Henry Schein Inc, Midwest Veterinary Supply, Inc., Merritt Veterinary Supplies, Inc., and Victor Medical Company.
Founded by veterinarians and experienced industry professionals who share a deep respect for the human-animal bond, Summit VetPharm will be uniquely focused on servicing professional veterinarians and their staff. Summit VetPharm will provide:
- Veterinarian-friendly policies and procedures
- High-performance, well-trained representatives
- Data and continuous education to support our products
- In-depth knowledge of pet owners and their decision-making process
Summit VetPharm will also provide education for the veterinary healthcare team, including continuing education, clinical research articles, and veterinary school programs.
Summit VetPharm
Founded by veterinarians and experienced industry professionals, Summit VetPharm is committed to protecting the health and welfare of both companion animals and companion animal veterinary practices. As a wholly-owned subsidiary of the Sumitomo Corporation and part of the Sumitomo Corporation group of companies, Summit VetPharm is backed by a longstanding reputation for values and ethics in business and is dedicated to raising the standards in animal health. Summit VetPharm is headquartered in Fort Lee, New Jersey, USA . For more information, visit Summit VetPharm at www.summitvetpharm.comFOR IMMEDIATE RELEASE
July 14, 2007
Contact: Jewelle Yamada – (212) 207-0574
Summit VetPharm Debuts Innovative Bloodhound™ Technology To Ensure Veterinary Exclusivity of its Products
Summit VetPharm, LLC, a newly formed animal healthcare company, introduces its proprietary Bloodhound™ Technology — an innovative track and trace system developed by Nutec Systems that will help ensure the veterinary exclusivity of its products. This groundbreaking technology differs from similar tracking systems in that it ensures all Summit VetPharm products can be traced from the point of manufacture to veterinary purchase. Bloodhound™ tracks individual clinics that purchase its products and guarantees sale to consumers only through licensed veterinarians.
Bloodhound™ Technology will allow Summit VetPharm to guard against counterfeiting, and maintain the integrity of its products through a secure distribution channel. Veterinary exclusivity improves compliance by ensuring appropriate product usage and increasing awareness with more client visits and opportunities for education.
“By securing our supply chain, we are able to protect the veterinary professional, maintain authenticity of our products, and enhance the role of veterinarians in the lives of the animals they treat. Through our Bloodhound™ Technology, we can help keep companion animal health exactly where it belongs — in the hands of professionals,” states Julia Stephanus, President of Summit VetPharm.
Bloodhound™ Technology is a state-of-the-art product track and trace system developed by Nutec Systems, a company with extensive experience in “start-to-finish” hardware and software implementation of product “print and inspect” systems. The system uses Unique Individual Identifiers (UID) which, together with a built-in covert anti-counterfeit feature, enables Summit VetPharm to identify counterfeit products with custom design software. Bloodhound™ is a service provided entirely and uniquely by Summit VetPharm, guaranteeing complete reliability and traceability with nothing additional required of its customers.
Summit VetPharm
Founded by veterinarians and experienced industry professionals, Summit VetPharm is committed to protecting the health and welfare of both companion animals and companion animal veterinary practices. As a wholly-owned subsidiary of the Sumitomo Corporation and part of the Sumitomo Corporation group of companies, Summit VetPharm is backed by a longstanding reputation for values and ethics in business and is dedicated to raising the standards in animal health. Summit VetPharm is headquartered in Fort Lee, New Jersey, USA . For more information, visit Summit VetPharm at www.summitvetpharm.com
Nutec Systems, Inc.
Nutec Systems has been the leader in the industrial thermal inkjet market and continues to develop inventive solutions by providing quality product handling systems combined with vision inspection. With a range of capabilities that includes the ability to fulfill all vision inspection requirements, Nutec consistently meets the printing specifications and quality demands of their clients. Nutec Systems is located in Lawrenceville, NJ, USA . For more information visit www.nutecsystems.com.
FOR IMMEDIATE RELEASE
July 14, 2007
Contact: Jewelle Yamada – (212) 207-0574
Newly launched Summit VetPharm Announces Co-Promotion Agreement with Abbott Animal Health
Summit VetPharm, a newly formed animal healthcare company headquartered in Fort Lee, New Jersey, announced the signing of a co-promotion agreement with Abbott Animal Health that co-promotes Summit VetPharm’s products. This new partnership will strengthen Summit VetPharm's contributions to veterinarian-client-patient care by combining the innovative products and commercial expertise of Summit with the sales capability and reach of Abbott Animal Health.
With a focus on the veterinary community, companion animals, and their owners, Summit VetPharm will offer a range of unique and innovative products and services to veterinary practices across the U.S.
Through this partnership, Summit VetPharm and Abbott will offer high-quality parasiticide products that are distributed exclusively through veterinarians to ensure safety and authenticity. This complementary partnership should bring important developments to the veterinary community in the coming years.
About Summit VetPharm:
Founded by veterinarians and experienced industry professionals, Summit VetPharm is committed to protecting the health and welfare of both companion animals and companion animal veterinary practices. As a wholly-owned subsidiary of the Sumitomo Corporation and part of the Sumitomo Corporation group of companies, Summit VetPharm is backed by a longstanding reputation for values and ethics in business and is dedicated to raising the standards in animal health. Summit VetPharm is headquartered in Fort Lee, New Jersey, USA . For more information, visit Summit VetPharm at www.summitvetpharm.com
FOR IMMEDIATE RELEASE
January 13, 2007
Contact: Jewelle Yamada – (212) 207-0574
Summit VetPharm launched:
New animal healthcare company to focus on companion animals and veterinarians
Summit VetPharm, a new animal healthcare company headquartered in Fort Lee, New Jersey, announces its entry into the field of companion animal veterinary products.
With a focus on serving the veterinary community, companion animals and their owners, Summit VetPharm is planning to offer a range of unique and valued products and services including parasiticides to veterinary practices in the U.S.
“Summit VetPharm is dedicated to helping companion animal veterinary professionals build their practices,” said Summit VetPharm’s president Julia Stephanus. “Summit VetPharm will provide exclusive products and services designed to enhance the veterinarian-client-patient relationship.”
Summit VetPharm will introduce its senior management and professional team to the veterinary community at the annual North American Veterinary Conference in Orlando, Florida this month.
“The last decade has seen remarkable advancements in animal healthcare, and Summit VetPharm looks to further extend the range of beneficial veterinary pharmaceutical options for companion pets and veterinarians,” said Dr. Ahn.
“We believe that the veterinarian should be in control of companion animal health,” said Dr. Ahn. “Our dedicated team of professionals will offer meaningful services that promote and extend the veterinarian’s practice.”
Founded by veterinarians who share a deep respect for the human-animal bond, Summit VetPharm will be uniquely focused on the professional veterinarian and their staff. Summit will provide:
- Veterinarian-friendly policies and procedures
- High-performance, well-trained people
- Supporting products with data and continuous education
- In-depth knowledge of pet owners and their decision-making process
Summit VetPharm will also provide education for the veterinary healthcare team, including continuing education, clinical research articles, and new client acquisition programs.
Summit VetPharm is a wholly-owned subsidiary of Sumitomo Corporation of America (SCOA).
About Sumitomo Corporation of America:
Established in 1952 and headquartered in Manhattan, New York, SCOA is the largest wholly owned subsidiary of Sumitomo Corporation, Japan, an integrated global trading firm with diversified investments and trading businesses. SCOA has offices in 10 major U.S. cities, and has over 40 subsidiary and affiliate companies including, The Hartz Mountain Corporation and TBC Corporation. Working closely with its parent SCOA is involved in such businesses as pharmaceuticals, agricultural products, PVC pipe manufacturing, steel service centers and tire distribution. For more information visit www.sumitomocorp.com.
